Increased bioavailability over other compounds that are currently available Ability to cross blood-brain barrier at organismal pH Rationally designed to bind optimally and produce greatest efficacy
[Detail]
The technology portfolio describes regulators of glutaminase(GLS1 & GLS2) and assay platforms for screening GLS1 & GLS2.
[Detail]